Hyperhidrosis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Hyperhidrosis Treatment Market Insights & Outlook and It is Segmented by Disease Type (Primary Focal Hyperhidrosis and Secondary Generalized Hyperhidrosis), Treatment Type (Topical Treatments, Disposable, Surgical Treatments, Botulin Toxin A, Iontophoresis, Laser Treatments, and Other Treatment Types), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD Million) for the Above Segments.

Hyperhidrosis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Hyperhidrosis Treatment Industry Overview

The hyperhidrosis treatment market is moderately competitive and consists of several major players. The prominent players in the market are AbbVie, Brickell Biotech, Eli Lilly and Company (Dermira), Advin Healthcare, and Dermavant Scienecs Inc. (Roivant Sci), among others. The companies operating in the market are focusing on R&D investments and fundraising activities to conduct clinical trials that lead to strong product pipelines.

Hyperhidrosis Treatment Market Leaders

  1. AbbVie Inc.

  2. Eli Lilly (Dermira)

  3. Advin Health Care

  4. Dermavant (Roivant Sciences)

  5. Brickell Biotech Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Hyperhidrosis Treatment Market _ CL_New.png